Slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our User Agreement and Privacy Policy.

Slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our Privacy Policy and User Agreement for details.

Profarma 4 q12

3.
Highlights in the Period• The Companys consolidated net income rose by 53.6% year-over-year to R$ 40.6 million, with net margin of 1.3%;• Consolidated gross revenues increased 14.6% year-over-year and totaled R$ 3.8 billion. It is worth noting the generics and health and beauty categories, which increased by 29.6% and 22.8% respectively;• Consolidated EBITDA climbed by 26.4% against 2011 and came to R$ 92.2 million, with 2.9% EBITDA margin;• A drop of 1.7 days in the Companys cash cycle when compared with 2011, to 46.3 days. This decrease resulted in a fall of about R$ 21.6 million in working capital;• The acquisition of 80% of Arp Med S.A.’s capital for a multiple EV/EBITDA (2012E) of 5.3x was approved by CADE on December 28, 2012.Subsequent events*:• On January 17, 2013, the Company acquired 100% of Drogasmil and Farmalife drugstore chains, with 85 stores in Rio de Janeiro State, for R$ 87.0 million, to be paid net of the debt level of the company;• On January 30, 2013, the Company acquired 50% of Drogarias Tamoio chain, which consists of 57 stores in Rio de Janeiro State. The transaction was made by means of a primary subscription of R$ 62.3 million and a secondary subscription of R$ 43.1 million, with a multiple EV/EBITDA (2013E) of 7.5x;• On February 21, 2013, Profarma entered into a joint venture agreement with Nutrilatina to create Supernova. With this move, Profarma has become the exclusive distributor of Nutrilatinas products to pharmaceutical retailers and entered a new market, body shops, also as a sole distributor.* These transactions have to be approved by CADE - with the exception of Supernova. 3